THIS AGREEMENT is made on 9/26/2021.Agreement • March 21st, 2024 • Exscientia PLC • Biological products, (no disgnostic substances)
THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 21st, 2024 • Exscientia PLC • Biological products, (no disgnostic substances) • New York
This Third Amendment to Collaboration and License Agreement (the “Third Amendment”) is entered into as of December 20, 2023 (the “Third Amendment Date”) by and between Exscientia Al Limited, registered in Scotland under SC42876 l, whose registered office is at Level 3, Dundee One River Court, 5 West Victoria Dock Road, Dundee, United Kingdom (“EXS”), and Sanofi, a French Société Anonyme, having its registered head office at 46-48 Avenue de la Grande Armée, 75017 Paris (“Sanofi”). EXS and Sanofi are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
RESEARCH COLLABORATION AGREEMENT dated September 19, 2023 by and between EXSCIENTIA AI LTD. and MERCK HEALTHCARE KGAAResearch Collaboration Agreement • March 21st, 2024 • Exscientia PLC • Biological products, (no disgnostic substances)
Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.
